Skip to main content

Inaugural lecture Prof. Dr. Oya Tagit

When Nano Meets Bio: Engineered Nanoparticles for Modulation and Monitoring of Biological Systems

Our Professor of BioInterphases Dr. Oya Tagit tells us more about Engineered Nanoparticles for Modulation and Monitoring of Biological Systems in her inaugural lecture.
The inaugural lecture will take place in room 02.O.18. After the lecture, all guests are invited to an aperitif at the Restaurant Cube at the FHNW Campus Muttenz.

Datum und Zeit

08.06.2022 15:00 - 17:00 iCal

Ort

02.O.18
FHNW Campus Muttenz, Hofackerstrasse 30, 4132 Muttenz

Veranstaltet durch

Hochschule für Life Sciences

For online participation please click here.

The rapidly growing field of nanoscience and nanotechnology has expanded the range of materials that can provide innovative and radical solutions to the unmet biomedical needs, among others. Recently, nanoparticles precisely engineered at the nanoscale (1-100 x 10-9 meters) have emerged as novel therapeutic and diagnostic agents due to their unique physicochemical properties (e.g. optical, magnetic, electronic, etc.) that are dictated by their size, shape, composition, surface; and can be customized for the desired biological targets and functions. With applications ranging from imaging and detection probes to nanocarriers for (bio)therapeutics delivery, engineered nanoparticles can give unprecedented information on the chemical and physical processes that take place in biological systems, and enable targeted therapeutic interventions.

This lecture delves into interdisciplinary approaches -at the interface between materials chemistry, nanotechnology, and biology- for the design, development, and deployment of inorganic and polymeric nanoparticles as optical detection probes, (pre-)clinical imaging agents, and drug delivery systems. Specific examples of colloidal synthesis, bioconjugation, and detection strategies are highlighted for highly sensitive in vitro diagnostics of cancer with luminescent inorganic nanoparticles. In addition, considerations for clinical development of polymeric nanoparticle formulations are discussed featuring (bio)therapeutics delivery for cancer immunotherapy. The outlook reflects how nanoparticles can be engineered for multi-tasking to carry out multiple functions simultaneously and can help overcome barriers associated with conventional diagnosis and treatment approaches.

FHNW Campus Muttenz

Fachhochschule Nordwestschweiz FHNW Hofackerstrasse 30 4132 Muttenz
Diese Seite teilen: